Patents by Inventor Wendy Johnson

Wendy Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200368149
    Abstract: A topical anesthetic composition for pain relief. The composition includes an anesthetic, such as bupivacaine, formulated for topical administration and transdermal delivery of the anesthetic. The composition can be applied to the skin of an individual to alleviate localized pain due to acute or chronic injuries or health conditions.
    Type: Application
    Filed: April 23, 2020
    Publication date: November 26, 2020
    Inventor: Wendy Johnson
  • Publication number: 20130097755
    Abstract: A new and distinct variety of strawberry plant named ‘Buddy’ particularly characterized by an everbearing plant with good vigor, producing attractive, glossy berries with excellent eating quality, is disclosed.
    Type: Application
    Filed: August 29, 2012
    Publication date: April 18, 2013
    Applicant: HARGREAVES PLANTS LIMITED
    Inventors: David William Simpson, Adam Barrie Whitehouse, Abigail Wendy Johnson
  • Patent number: 8044022
    Abstract: Several species of bacteria capable of invasive infections, such as S. pyogenes, S. equi and P. multocida, contain hyaluronic acid (HA) in their capsules. Bacterial species such as Staphylococcus aureus and related Staphylococci have capsules that contain acidic polysaccharides. Bacterial capsule or bacterial surface binding peptides were synthesized and tested in a culture model of invasive bacterial infections, specifically translocation through polarized keratinocyte cultures. The peptides reduced the translocation of a variety of bacterial species, with a concomitant increase in bacterial internalization by the keratinocytes. In vivo, subcutaneous inoculation of encapsulated GAS treated with peptides delayed bacterial dissemination. In a mouse surgical wound model infected with S. aureus, treatment with peptides reduced the numbers of bacteria and inflammation at the wound site.
    Type: Grant
    Filed: June 8, 2006
    Date of Patent: October 25, 2011
    Inventors: Tadeusz Kolodka, Bernard T. Charlton, Wendy Johnson
  • Publication number: 20090030180
    Abstract: Several species of bacteria capable of invasive infections, such as S. pyogenes, S. equi and P. multocida, contain hyaluronic acid (HA) in their capsules. Bacterial species such as Staphylococcus aureus and related Staphylococci have capsules that contain acidic polysaccharides. Bacterial capsule or bacterial surface binding peptides were synthesized and tested in a culture model of invasive bacterial infections, specifically translocation through polarized keratinocyte cultures. The peptides reduced the translo-cation of a variety of bacterial species, with a concomitant increase in bacterial internalization by the keratinocytes. In vivo, subcutaneous inoculation of encapsulated GAS treated with peptides delayed bacterial dissemination. In a mouse surgical wound control model infected with S. aureus, treatment with peptides reduced the numbers of bacteria and inflammation at the wound site.
    Type: Application
    Filed: June 8, 2006
    Publication date: January 29, 2009
    Applicant: CANGENE CORPORATION
    Inventors: Tadeusz Kolodka, Bernard T. Charlton, Wendy Johnson
  • Publication number: 20070184117
    Abstract: A powdered tocopheryl polyethylene glycol succinate (TPGS™) having an average particle size of less than about 1000 microns. In one embodiment, the powdered tocopheryl polyethylene glycol succinate is prepared by a process that includes atomizing a fluidic tocopheryl polyethylene glycol succinate into an environment suitable for solidifying the atomized tocopheryl polyethylene glycol succinate. In another embodiment, the powdered tocopheryl polyethylene glycol succinate is prepared by a process of applying a force to a solid tocopheryl polyethylene glycol succinate starting material that is sufficient to produce a powdered product.
    Type: Application
    Filed: July 26, 2006
    Publication date: August 9, 2007
    Inventors: Stephen Gregory, Bruce Jones, Andy Singleton, Wendy Johnson
  • Patent number: 7148202
    Abstract: Filamentous phage particles displaying a ligand on their surface are used to deliver a therapeutic gene to a cell. The ligand is a fusion protein with a phage capsid protein, covalently conjugated to phage particles, or complexed with modified phage particles.
    Type: Grant
    Filed: June 12, 2002
    Date of Patent: December 12, 2006
    Assignee: Selective Genetics, Inc.
    Inventors: David Larocca, Andrew Baird, Wendy Johnson
  • Publication number: 20030082143
    Abstract: Filamentous phage particles displaying a ligand on their surface are used to deliver a therapeutic gene to a cell. The ligand is a fusion protein with a phage capsid protein, covalently conjugated to phage particles, or complexed with modified phage particles.
    Type: Application
    Filed: June 12, 2002
    Publication date: May 1, 2003
    Applicant: Selective Genetics, Inc.
    Inventors: David Larocca, Andrew Baird, Wendy Johnson
  • Patent number: 6448083
    Abstract: Filamentous phage particles displaying a ligand on their surface are used to deliver a therapeutic gene to a cell. The ligand is a fusion protein with a phage capsid protein, covalently conjugated to phage particles, or complexed with modified phage particles.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: September 10, 2002
    Assignee: Selective Genetics, Inc.
    Inventors: David Larocca, Andrew Baird, Wendy Johnson
  • Patent number: 6428808
    Abstract: The invention relates to a method for preparing a flavored liquid medicament, particularly a pediatric preparation in solid form.
    Type: Grant
    Filed: August 21, 2000
    Date of Patent: August 6, 2002
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Philip Christopher Buxton, Janice Duncan, Wendy Johnson, Geoffrey David Tovey
  • Patent number: 6054312
    Abstract: Filamentous phage particles displaying a ligand on their surface are used to deliver a therapeutic gene to a cell. The ligand is a fusion protein with a phage capsid protein, covalently conjugated to phage particles, or complexed with modified phage particles.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: April 25, 2000
    Assignee: Selective Genetics, Inc.
    Inventors: David Larocca, Andrew Baird, Wendy Johnson
  • Patent number: 5897025
    Abstract: A container for dispensing tablets in which the dispensing opening and/or a dispensing passage upstream of the dispensing opening is constricted such that a tablet is releasably retained with part of the tablet projecting outside of the dispensing opening. The part of the rim of the dispensing opening or an adjacent part of the container is movable relative to the rest of the container so as to facilitate the release of the retained tablet from the container.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: April 27, 1999
    Assignee: SmithKline Beecham plc.
    Inventors: Harry Flewitt, Wendy Johnson, Stephen Barnet Lewis
  • Patent number: PP24512
    Abstract: A new and distinct variety of strawberry plant named ‘Buddy’ particularly characterized by an everbearing plant with good vigor, producing attractive, glossy berries with excellent eating quality, is disclosed.
    Type: Grant
    Filed: August 29, 2012
    Date of Patent: June 3, 2014
    Assignee: Hargreaves Plants Limited
    Inventors: David William Simpson, Adam Barrie Whitehouse, Abigail Wendy Johnson